Cite
Mok CKP, Cohen CA, Cheng SMS, et al. Comparison of the immunogenicity of BNT162b2 and CoronaVac COVID-19 vaccines in Hong Kong. Respirology. 2021;doi: 10.1111/resp.14191.
Mok, C. K. P., Cohen, C. A., Cheng, S. M. S., Chen, C., Kwok, K. O., Yiu, K., Chan, T. O., Bull, M., Ling, K. C., Dai, Z., Ng, S. S., Lui, G. C., Wu, C., Amarasinghe, G. K., Leung, D. W., Wong, S. Y. S., Valkenburg, S. A., Peiris, M., & Hui, D. S. (2021). Comparison of the immunogenicity of BNT162b2 and CoronaVac COVID-19 vaccines in Hong Kong. Respirology (Carlton, Vic.), . https://doi.org/10.1111/resp.14191
Mok, Chris Ka Pun, et al. "Comparison of the immunogenicity of BNT162b2 and CoronaVac COVID-19 vaccines in Hong Kong." Respirology (Carlton, Vic.) vol. (2021). doi: https://doi.org/10.1111/resp.14191
Mok CKP, Cohen CA, Cheng SMS, Chen C, Kwok KO, Yiu K, Chan TO, Bull M, Ling KC, Dai Z, Ng SS, Lui GC, Wu C, Amarasinghe GK, Leung DW, Wong SYS, Valkenburg SA, Peiris M, Hui DS. Comparison of the immunogenicity of BNT162b2 and CoronaVac COVID-19 vaccines in Hong Kong. Respirology. 2021 Nov 24; doi: 10.1111/resp.14191. Epub 2021 Nov 24. PMID: 34820940.
Copy
Download .nbib